Skip to content

Self management of urinary symptoms after prostate cancer treatment

Self-management of urinary symptoms after treatment for prostate cancer: an exploratory randomised controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN20069765
Enrollment
96
Registered
2012-03-13
Start date
2011-03-01
Completion date
Unknown
Last updated
2024-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer Cancer Malignant neoplasm of prostate

Interventions

Supported self-management delivered by a specialist prostate cancer nurse comprising four group sessions and one individual session. The intervention will contain both behavioural and cognitive elemen

Sponsors

University of Surrey (UK)
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Men 2. Have locally contined prostate cancer up to stage T3BNO 3. Have received neoadjuvant hormonal therapy 4. Have completed radiotherapy three to four months prior to the intervention 5. Have urinary syptopms and an IPSS score of 8+ 6. Have sufficient understanding of written and spoken English Added 27/01/2014: 7. Brachytherapy patients

Exclusion criteria

Exclusion criteria: 1. Have a urinary tract infection 2. Have a current psychiatric referral 3. Have a current referral for memory issues 4. Require an interpreter

Design outcomes

Primary

MeasureTime frame
Urinary syptoms measured by the International Prostate Symptom Score (IPSS); Timepoint(s): At two months (end of intervention) and 6 months past baseline

Secondary

MeasureTime frame
Quality of life measured by the EORTC 25, and emotional distress measured by the EORTC 30 ? both at 2 and 6 months post baseline.

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026